Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hylase Wound Gel (Marketing and Distribution Rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

A topical wound gel products' rights. The company offers product, for the management and treatment of leg ulcers, pressure ulcers, diabetic ulcers and exuding wounds prone to bleeding.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 10 Mountainview Road South
  • Suite 207
  • Georgetown, Ontario L7G 4J9
  • Canada

Hylase Wound Gel (Marketing and Distribution Rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Hylase Wound Gel (Marketing and Distribution Rights)‘s full profile, request access.

Request full access to PitchBook

Hylase Wound Gel (Marketing and Distribution Rights) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Hylase Wound Gel (Marketing and Distribution Rights)‘s full profile, request access.

Request full access to PitchBook